If defense prevails, the case could reinforce the latitude clinicians have in pain management and limit the reach of fraud claims based on marketing statements, but regulatory attention would likely persist.
A landmark courtroom battle—known in filings as Lomps Court Case 1—has exposed a clash between a boutique pain-management clinic, Elite Pain, and former patients alleging deceptive practices and unsafe care. Over six weeks of testimony, sworn statements and sealed documents, the trial revealed systemic concerns about prescriptions, business incentives, and the oversight of outpatient pain clinics. lomps court case 1 elite pain full link